Peer-reviewedCC BY 4.0Frontiers in Immunology
Beyond PET/CT: the evolving role of circulating tumor DNA in follicular lymphoma
- 1Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA)
- 2Altum Sequencing S.L.
- 3Hematology Department, Hospital Universitario 12 de Octubre
Related
- Circulating tumor DNA in body fluids for molecular characterization of cancers beyond tissue and blood
- Prognostic value of circulating cell-free Epstein-Barr virus DNA CpG methylation in extranodal NK/T cell lymphoma
- Beyond the tangled bank: An evolving meta‐ecosystems framework to integrate ecological and evolutionary perspectives
- Early-Onset Brain Tumor and Lymphoma in MSH2-Deficient Children
- 434 Phenotypic state of circulating tumor-reactive T cells predict response to PD-1 blockade in non-small cell lung cancer
BibTeX
@article{barrio2026beyond,
title = {{Beyond PET/CT: the evolving role of circulating tumor DNA in follicular lymphoma}},
author = {Santiago Barrio and Alejandro Martín-Muñoz and Ana Jiménez-Ubieto},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1978141},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1978141/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Beyond PET/CT: the evolving role of circulating tumor DNA in follicular lymphoma
AU - Santiago Barrio
AU - Alejandro Martín-Muñoz
AU - Ana Jiménez-Ubieto
PY - 2026
DA - 2026/10/27
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1978141
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1978141/full
SN - 1664-3224
ER -